STRS Ohio’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,300
Closed -$1.49M 1991
2017
Q3
$1.49M Hold
8,300
0.01% 703
2017
Q2
$860K Buy
8,300
+2,600
+46% +$212K ﹤0.01% 905
2017
Q1
$447K Buy
+5,700
New +$352K ﹤0.01% 1360
2016
Q4
Sell
-3,200
Closed -$178K 2034
2016
Q3
$178K Buy
3,200
+800
+33% +$44.6K ﹤0.01% 1577
2016
Q2
$120K Buy
+2,400
New +$118K ﹤0.01% 1662
2016
Q1
Sell
-900
Closed -$43.6K 1961
2015
Q4
$55K Buy
+900
New +$63.4K ﹤0.01% 1784
2015
Q3
Sell
-17,800
Closed -$1.12M 1988
2015
Q2
$1.08M Buy
17,800
+14,900
+514% +$850K ﹤0.01% 810
2015
Q1
$167K Sell
2,900
-100
-3% -$6.7K ﹤0.01% 1514
2014
Q4
$173K Hold
3,000
﹤0.01% 1470
2014
Q3
$86K Buy
+3,000
New +$74.2K ﹤0.01% 1590

STRS Ohio's KITE Position: Q4 2017 in Review

STRS Ohio sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 8,300 shares — an estimated $1.49M sold.

STRS Ohio first reported a position in KITE in Q3 2014 and held it in 10 quarters. The position peaked at $1.49M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • STRS Ohio reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • STRS Ohio sold 8,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.49M.
  • STRS Ohio first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 10 quarters.
  • STRS Ohio's Kite Pharma, Inc. position peaked at $1.49M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on STRS Ohio's 13F filing for Q4 2017, filed 23 Jan 2018.